In France, from March 19 to 25, three cases of thrombosis were detected after vaccination with the drug from AstraZeneca, two cases ended in death, the report says. It is noted that we are talking about ” atypical deep vein thrombosis in its localization, which may be associated with thrombocytopenia (platelet deficiency in the blood) or with coagulation disorders.”
A total of 12 cases of thrombosis have been recorded in France since the start of the campaign to vaccinate the population against coronavirus infection. Four of them were fatal.
Currently, some EU countries have suspended vaccination with AstraZeneca due to reported thromboembolic complications in vaccinated patients. The European Medicines Agency (EMA) is investigating the incidents, but for now, it considers it possible to continue vaccination.